ANI Pharmaceuticals, Inc.
DE ˙ DB ˙ US00182C1036
€ 54,50 0.00 (0.00%)
2023-08-21
PREÇO DA AÇÃO
SecurityDE:BSFA / ANI Pharmaceuticals, Inc.
InstitutionStifel Financial Corp
Latest Disclosed Ownership10,771 shares
Latest Disclosed Value $ 828,304
Stifel Financial Corp reports 0.45% increase in ownership of BSFA / ANI Pharmaceuticals, Inc.

On May 12, 2026 - Stifel Financial Corp filed a 13F-HR form disclosing ownership of 10,771 shares of ANI Pharmaceuticals, Inc. (DE:BSFA) valued at $828,304 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 10,723 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of 0.45% during the quarter. The current value of the position is $587,020 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ANI PHARMACEUTICALS COM 00182C103 10,771 48 0.45 828 -2.13 0.0002
2026-02-13 2025-12-31 13F ANI PHARMACEUTICALS COM 00182C103 10,723 1,762 19.66 846 3.17 0.0008
2025-11-12 2025-09-30 13F ANI PHARMACEUTICALS COM 00182C103 8,961 -177 -1.94 821 37.58 0.0007
2025-08-14 2025-06-30 13F ANI PHARMACEUTICALS COM 00182C103 9,138 -145 -1.56 596 -4.03 0.0006
2025-05-14 2025-03-31 13F ANI PHARMACEUTICALS COM 00182C103 9,283 859 10.20 622 33.55 0.0007
2025-02-13 2024-12-31 13F ANI PHARMACEUTICALS COM 00182C103 8,424 1,425 20.36 466 11.51 0.0005
2024-11-14 2024-09-30 13F ANI PHARMACEUTICALS COM 00182C103 6,999 6,999 418 0.0004
2020-05-14 2020-03-31 13F ANI PHARMACEUTICALS COM 00182C103 0 -3,245 -100.00 0 -100.00
2020-02-13 2019-12-31 13F ANI PHARMACEUTICALS COM 00182C103 3,245 450 16.10 201 -0.99 0.0004
2019-11-19 2019-09-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 2,795 -126 -4.31 203 -16.12 0.0005
2019-11-13 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 2,795 -126 203 113.7917
2019-08-14 2019-06-30 13F ANI PHARMACEUTICALS COM 00182C103 2,921 -114 -3.76 242 13.08 0.0006
2019-05-14 2019-03-31 13F ANI PHARMACEUTICALS COM 00182C103 3,035 3,035 214 0.0006
2019-02-13 2018-12-31 13F ANI PHARMACEUTICALS COM 00182C103 0 -3,847 -100.00 0 -100.00
2018-11-13 2018-09-30 13F ANI PHARMACEUTICALS COM 00182C103 3,847 17 0.44 217 -15.23 0.0006
2018-08-14 2018-06-30 13F ANI PHARMACEUTICALS COM 00182C103 3,830 164 4.47 256 19.07 0.0008
2018-05-11 2018-03-31 13F ANI PHARMACEUTICALS COM 00182C103 3,666 3,666 215 0.0007
2018-02-14 2017-12-31 13F ANI PHARMACEUTICALS COM 00182C103 0 -6,703 -100.00 0 -100.00
2017-11-13 2017-09-30 13F ANI PHARMACEUTICALS COM 00182C103 6,703 6,703 349 0.0012
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.